• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项探索患者如何识别和评估作为药物不良反应的症状的定性研究。

A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions.

作者信息

Chaipichit Nataporn, Krska Janet, Pratipanawatr Thongchai, Uchaipichat Verawan, Jarernsiripornkul Narumol

机构信息

Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand.

出版信息

Eur J Clin Pharmacol. 2014 May;70(5):607-15. doi: 10.1007/s00228-014-1653-6. Epub 2014 Feb 16.

DOI:10.1007/s00228-014-1653-6
PMID:24531695
Abstract

PURPOSE

To explore how Thai patients assess symptoms as adverse drug reactions (ADRs).

METHODS

Out-patients at two hospitals in Thailand previously reporting suspected ADRs to statins were purposively selected to cover factors relevant to the accuracy of ADR reports. Semi-structured interviews explored the mechanisms participants used to work out whether their symptoms were related to their statin. All interviews were audio-recorded, transcribed and independently thematically analyzed by two researchers.

RESULTS

One hundred interviews were suitable for analysis; 52 were male, age range was 36 to 77 years (mean ± S.D.: 59.83 ± 9.14) and most (92) were taking other medicines in addition to statins. Patient assessment of symptoms as ADRs fell into two major themes: medicine-related factors and external factors. Timing relationships were mentioned most frequently (74), followed by information received (55), seeing similar symptoms in others (7) and diagnosis through blood tests (4). Use of multiple medicines, consideration of the medicine versus diseases, symptoms occurring with more than one medicine or relieved through treatment reduced confidence in ADR attribution. Many participants proposed alternative explanations for symptoms, including old age. Lack of information and knowledge were obstacles to the assessment process.

CONCLUSIONS

Patients assessed possible ADRs most often by considering timing relationships. While they also used medicine information, Thai patients received inadequate information to help them assess their symptoms. Patients expressed uncertainty and difficulties in deciding attribution when concomitant medicines and diseases were involved. The findings could support the development of a patient-friendly systematic tool for identifying and assessing possible ADRs.

摘要

目的

探讨泰国患者如何将症状评估为药物不良反应(ADR)。

方法

有目的地选取泰国两家医院之前报告过他汀类药物疑似ADR的门诊患者,以涵盖与ADR报告准确性相关的因素。通过半结构化访谈探究参与者用于判断其症状是否与他汀类药物有关的机制。所有访谈均进行录音、转录,并由两名研究人员独立进行主题分析。

结果

100份访谈适合进行分析;其中52名男性,年龄范围为36至77岁(平均±标准差:59.83±9.14),大多数(92名)患者除服用他汀类药物外还在服用其他药物。患者将症状评估为ADR主要分为两个主题:药物相关因素和外部因素。最常被提及的是时间关系(74例),其次是所获得的信息(55例)、在他人身上看到类似症状(7例)以及通过血液检查进行诊断(4例)。使用多种药物、对药物与疾病的考虑、一种以上药物出现的症状或经治疗缓解的症状会降低对ADR归因的信心。许多参与者对症状提出了其他解释,包括年龄较大。信息和知识的缺乏是评估过程中的障碍。

结论

患者最常通过考虑时间关系来评估可能的ADR。虽然他们也利用药物信息,但泰国患者获得的信息不足以帮助他们评估症状。当涉及合并用药和疾病时,患者在确定归因方面表现出不确定性和困难。这些发现可为开发一种方便患者使用的系统工具以识别和评估可能的ADR提供支持。

相似文献

1
A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions.一项探索患者如何识别和评估作为药物不良反应的症状的定性研究。
Eur J Clin Pharmacol. 2014 May;70(5):607-15. doi: 10.1007/s00228-014-1653-6. Epub 2014 Feb 16.
2
The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.加纳患者在药物不良反应报告中的贡献:一项定量和定性研究。
BMC Public Health. 2018 Dec 18;18(1):1384. doi: 10.1186/s12889-018-6285-9.
3
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况:文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
4
Public confidence in ADR identification and their views on ADRreporting: mixed methods study.公众对药品不良反应识别的信心及其对药品不良反应报告的看法:混合方法研究
Eur J Clin Pharmacol. 2017 Feb;73(2):223-231. doi: 10.1007/s00228-016-2155-5. Epub 2016 Nov 11.
5
Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand.泰国患者对非甾体抗炎药潜在药物不良反应的自我报告
Pharm World Sci. 2009 Oct;31(5):559-564. doi: 10.1007/s11096-009-9310-3. Epub 2009 Jul 4.
6
Confidence and accuracy in identification of adverse drug reactions reported by outpatients.门诊患者报告的药物不良反应识别的可信度和准确性。
Int J Clin Pharm. 2018 Dec;40(6):1559-1567. doi: 10.1007/s11096-018-0732-7. Epub 2018 Oct 26.
7
Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.消费者准备好参与药物警戒系统了吗?——一项关于药品不良反应报告的葡萄牙初步研究。
Eur J Clin Pharmacol. 2015 Jul;71(7):883-90. doi: 10.1007/s00228-015-1867-2. Epub 2015 May 26.
8
Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.沙特阿拉伯达曼医疗保健人员对药物警戒及药品不良反应报告流程的知识、实践与态度
Curr Drug Saf. 2018;13(1):21-25. doi: 10.2174/1574886313666171218123802.
9
Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand.社区药剂师对补充药物不良反应报告的看法和经验:新西兰的一项定性研究。
Drug Saf. 2020 Nov;43(11):1157-1170. doi: 10.1007/s40264-020-00980-x.
10
Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.尼日利亚门诊患者对不良反应的知识、意识、看法和报告。
Int J Clin Pharm. 2019 Aug;41(4):1062-1073. doi: 10.1007/s11096-019-00849-9. Epub 2019 May 28.

引用本文的文献

1
Evaluation of a self-screening tool and patient alert cards to help patients identify and manage severe adverse drug reactions.评估一种自我筛查工具和患者警示卡,以帮助患者识别和管理严重药物不良反应。
Int J Clin Pharm. 2025 Jun;47(3):726-736. doi: 10.1007/s11096-025-01864-9. Epub 2025 Jan 20.
2
Patients' Identification, Management and Prevention of Adverse Drug Reactions: A Cross-Sectional Survey of Patients with Severe Adverse Drug Reactions.患者不良药物反应的识别、管理与预防:对严重不良药物反应患者的横断面调查
J Clin Med. 2024 Jul 16;13(14):4165. doi: 10.3390/jcm13144165.
3
Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study.

本文引用的文献

1
Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire.患者报告的药物不良事件问卷的开发与初步验证
Drug Saf. 2013 Sep;36(9):765-77. doi: 10.1007/s40264-013-0036-8.
2
Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study.药师参与对患者报告药物不良反应的影响:意大利的首次研究。
Drug Saf. 2013 Apr;36(4):267-76. doi: 10.1007/s40264-013-0028-8.
3
Adherence to lipid-lowering treatment: the patient perspective.降脂治疗的依从性:患者视角
患者报告的药物不良反应及其识别的准确性:一项混合方法研究。
Int J Clin Pharm. 2024 Apr;46(2):401-410. doi: 10.1007/s11096-023-01669-8. Epub 2023 Dec 27.
4
Comparing patient reported and medical record data of adverse drug reactions to anti-seizure drugs.比较抗癫痫药物不良反应的患者报告和病历数据。
Int J Clin Pharm. 2024 Feb;46(1):101-110. doi: 10.1007/s11096-023-01653-2. Epub 2023 Oct 16.
5
Understanding Patient Needs Regarding Adverse Drug Reaction Reporting Smartphone Applications: A Qualitative Insight from Saudi Arabia.了解患者对药物不良反应报告智能手机应用程序的需求:来自沙特阿拉伯的定性见解。
Int J Environ Res Public Health. 2021 Apr 7;18(8):3862. doi: 10.3390/ijerph18083862.
6
Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand.社区药剂师对补充药物不良反应报告的看法和经验:新西兰的一项定性研究。
Drug Saf. 2020 Nov;43(11):1157-1170. doi: 10.1007/s40264-020-00980-x.
7
Use of information sources regarding medicine side effects among the general population: a cross-sectional survey.普通人群中药物副作用信息来源的使用情况:一项横断面调查。
Prim Health Care Res Dev. 2019 Dec 10;20:e153. doi: 10.1017/S1463423619000574.
8
Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care.糖尿病患者经历的药物不良事件模式:一项初级保健中的日记研究。
Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1175-1179. doi: 10.1002/pds.4839. Epub 2019 Jun 17.
9
Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR.移动应用程序在药品安全信息收集和交流方面的使用建议:来自 IMI WEB-RADR 的经验教训。
Drug Saf. 2019 Apr;42(4):477-489. doi: 10.1007/s40264-019-00813-6.
10
The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.加纳患者在药物不良反应报告中的贡献:一项定量和定性研究。
BMC Public Health. 2018 Dec 18;18(1):1384. doi: 10.1186/s12889-018-6285-9.
Patient Prefer Adherence. 2012;6:805-14. doi: 10.2147/PPA.S29092. Epub 2012 Nov 8.
4
Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.患者与医疗保健专业人员自发药物不良反应报告:系统评价。
Drug Saf. 2012 Oct 1;35(10):807-18. doi: 10.1007/BF03261977.
5
Patient reporting of suspected adverse drug reactions to antiepileptic drugs: factors affecting attribution accuracy.患者报告抗癫痫药物疑似不良反应:影响归因准确性的因素。
Epilepsy Behav. 2012 May;24(1):102-6. doi: 10.1016/j.yebeh.2012.03.023. Epub 2012 Apr 18.
6
A patient's perspective: the impact of adverse drug reactions on patients and their views on reporting.患者视角:药物不良反应对患者的影响及其对报告的看法。
J Clin Pharm Ther. 2012 Apr;37(2):148-52. doi: 10.1111/j.1365-2710.2011.01258.x. Epub 2011 May 18.
7
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况:文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
8
How patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK Yellow Card Scheme.患者记者如何识别药物不良反应:通过英国黄卡计划报告的定性研究。
Drug Saf. 2011 May 1;34(5):429-36. doi: 10.2165/11589320-000000000-00000.
9
Patient experiences of serious adverse drug reactions and their attitudes to medicines: a qualitative study of survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK.患者对严重药物不良反应的体验及其对药物的态度:英国史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症幸存者的定性研究。
Drug Saf. 2011 Apr 1;34(4):319-28. doi: 10.2165/11588460-000000000-00000.
10
Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.英国的药物不良反应报告:患者和医疗保健专业人员提交的黄卡报告的回顾性观察比较。
Drug Saf. 2010 Sep 1;33(9):775-88. doi: 10.2165/11536510-000000000-00000.